Increased high sensitivity C-reactive protein and neutrophil count are related to increased standard cardiovascular risk factors in healthy Chinese men

International Journal of Cardiology

Volumn 110, Issue 2, 2006, Pages 191-198

  Yen, Men Luh ^a   Yang, Chi Yu ^a,b   Yen, B Linju ^c   Ho, Yi Lwun ^a   Cheng, Wern Cherng ^a   Bai, Chyi Huey ^d  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

^c NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^d SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Cardiovascular risk factors; Chinese; High sensitivity C reactive protein; Leukocyte count; Monocytes; Neutrophils

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CHINESE; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; CONTROLLED STUDY; DOSE RESPONSE; HIGH RISK POPULATION; HUMAN; HUMAN EXPERIMENT; ISCHEMIC HEART DISEASE; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MONOCYTE; MORTALITY; NEUTROPHIL COUNT; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BIOLOGICAL MARKERS; BODY MASS INDEX; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CHINA; CROSS-SECTIONAL STUDIES; HUMANS; INFLAMMATION; LEUKOCYTE COUNT; MALE; MIDDLE AGED; MONOCYTES; MULTIVARIATE ANALYSIS; NEUTROPHILS; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SENSITIVITY AND SPECIFICITY;

EID: 33646867184     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2005.07.034     Document Type: Article

References (42)

1. Alexander R.W. Inflammation and coronary artery disease. N Engl J Med 331 (1994) 468-469
2. Koenig W. Predicting risk and treatment benefit in atherosclerosis: the role of C-reactive protein. Int J Cardiol 98 (2005) 199-206
3. Haverkate F., Thompson S.G., Pyke S.D., Gallimore J.R., and Pepys M.B. Production of C-reactive protein and risk of coronary events in stable and unstable angina. European concerted action on thrombosis and disabilities angina pectoris study group. Lancet 349 (1997) 462-466
4. Mendall M.A., Patel P., Ballam L., Strachan D., and Northfield T.C. C-reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study. BMJ 312 (1996) 1061-1065
5. Kuller L.H., Tracy R.P., Shaten J., and Meilahn E.N. Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Multiple risk factor intervention trial. Am J Epidemiol 144 (1996) 537-547
6. Ridker P.M., Hennekens C.H., Buring J.E., and Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 342 (2000) 836-843
7. Tracy R.P., Psaty B.M., Macy E., et al. Lifetime smoking exposure affects the association of C-reactive protein with cardiovascular disease risk factors and subclinical disease in healthy elderly subjects. Arterioscler Thromb Vasc Biol 17 (1997) 2167-2176
8. Danesh J., and Pepys M.B. C-reactive protein in healthy and in sick populations. Eur Heart J 21 (2000) 1564-1565
9. Koenig W., Sund M., Frohlich M., et al. C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. Circulation 99 (1999) 237-242
10. Ridker P.M., Cushman M., Stampfer M.J., Tracy R.P., and Hennekens C.H. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 336 (1997) 973-979
11. Ridker P.M., Buring J.E., Shih J., Matias M., and Hennekens C.H. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation 98 (1998) 731-733
12. Kannel W.B., Anderson K., and Wilson P.W. White blood cell count and cardiovascular disease. Insights from the Framingham Study. JAMA 267 (1992) 1253-1256
13. Targher G., Seidell J.C., Tonoli M., Muggeo M., De Sandre G., and Cigolini M. The white blood cell count: its relationship to plasma insulin and other cardiovascular risk factors in healthy male individuals. J Intern Med 239 (1996) 435-451
14. Weiss S.J. Tissue destruction by neutrophils. N Engl J Med 320 (1989) 365-376
15. Zalai C.V., Kolodziegczyk M.D., Pilarski L., et al. Increased circulating monocyte activation in patients with unstable coronary syndrome. J Am Coll Cardiol 38 (2001) 1340-1347
16. Collaborating Center on Surveillance of Cardiovascular disease, Global Cardiovascular Infobase (2002), World Health Organization, Geneva
17. Statistics and analysis, leading causes of death (2002), Department of Health, Taipei
18. Hackam D.G., and Anand S.S. Emerging risk factors for atherosclerotic vascular disease: a critical review of the evidence. JAMA 290 (2003) 932-940
19. Yamada S., Gotoh T., Nakashima Y., et al. Distribution of serum C-reactive protein and its association with atherosclerotic risk factors in a Japanese population: Jichi Medical School Cohort Study. Am J Epidemiol 153 (2001) 1183-1190
20. Saito M., Ishimitsu T., Minami J., Ono H., Ohrui M., and Matsuoka H. Relations of plasma high-sensitivity C-reactive protein to traditional cardiovascular risk factors. Atherosclerosis 167 (2003) 73-79
21. Reddy K.S., and Yusuf S. Emerging epidemic of cardiovascular disease in developing countries. Circulation 97 (1998) 596-601
22. Chaturvedi N., McKeigue P.M., and Marmot M.G. Relationship of glucose intolerance to coronary risk in Afro-Caribbeans compared with Europeans. Diabetologia 37 (1994) 765-772
23. Danesh J., Collins R., Appleby P., and Peto R. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. JAMA 279 (1998) 1477-1482
24. Huang P.C., Yu S.L., Lin Y.M., and Chu C.L. Body weight in Chinese adults by sex, age and body height and criterion of obesity based on body mass index. J Chin Nutr Soc 17 (1992) 157-172
25. Pickering T. Recommendations for the use of home (self) and ambulatory blood pressure monitoring, for an American Society of Hypertension Ad Hoc panel. Am J Hypertens 9 (1996) 1-11
26. Roberts W.L., Sedrick R., Moulton L., Spencer A., and Rifai N. Evaluation of four automated high-sensitivity C-reactive protein methods: implications for clinical and epidemiological applications. Clin Chem 46 (2000) 461-468
27. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. JAMA 285 (2001) 2486-2497
28. Hu F.B. Dietary pattern analysis: a new direction in nutritional epidemiology. Curr Opin Lipidol 13 (2002) 3-9
29. Pankow J.S., Folsom A.R., and Cushman M. Familial and genetic determinants of systemic markers of inflammation: the NHLBI family heart study. Atherosclerosis 154 (2001) 681-689
30. Pahor M., Elam M.B., Garrison R.J., Kritchevsky S.B., and Applegate W.B. Emerging noninvasive biochemical measures to predict cardiovascular risk. Arch Intern Med 159 (1999) 237-245
31. Clyne B., and Olshaker J.S. The C-reactive protein. J Emerg Med 17 (1999) 1019-1025
32. Tousoulis D., Davies G., Stefanadis C., Toutouzas P., and Ambrose J.A. Inflammatory and thrombotic mechanisms in coronary atherosclerosis. Heart 89 (2003) 993-997
33. Frangogiannis N.G., Smith C.W., and Entman M.L. The inflammatory response in myocardial infarction. Cardiovasc Res l53 (2002) 31-47
34. Huang Z.S., Wang C.H., Yip P.K., Yang C.Y., and Lee T.K. In hypercholesterolemia, lower peripheral monocyte count is unique among the major predictors of atherosclerosis. Arterioscler Thromb Vasc Biol 16 (1996) 256-261
35. Das I. Raised C-reactive protein levels from smokers. Clin Chim Acta 153 (1985) 9-13
36. Corre F., Lellouch H., and Schwartz D. Smoking and leukocyte-counts. Results of an epidemiological survey. Lancet 2 (1971) 632-634
37. Petitti D.B., and Kipp H. The leukocyte count: associations with intensity of smoking and persistence of effect after quitting. Am J Epidemiol 123 (1986) 89-95
38. Ford E.S. Leukocyte count, erythrocyte sedimentation rate, and diabetes incidence in a national sample of US adults. Am J Epidemiol 155 (2002) 57-64
39. Memon R.A., Feingold K.R., and Grunfeld C. Cytokines and intermediary metabolism. In: Remick D.G., and Friedland J.S. (Eds). Cytokines in health and disease. 2nd ed. (1997), Marcel Dekker, New York 381-399
40. Lee Y.T., Lin R.S., Sung F.C., et al. Chin-Shan Community Cardiovascular Cohort in Taiwan-baseline data and five-year follow-up morbidity and mortality. J Clin Epidemiol 53 (2000) 838-846
41. Rafai N., and Ridker P.M. Population distributions of C-reactive protein in apparently healthy men and women in the United States: implications for clinical interpretation. Clin Chem 49 (2003) 666-669
42. Mosca L. C-reactive protein-to screen or not to screen?. N Engl J Med 347 (2002) 1615-1617